LEADER 01386nam0-2200409li-450 001 990000136890203316 005 20180312154831.0 035 $a0013689 035 $aUSA010013689 035 $a(ALEPH)000013689USA01 035 $a0013689 100 $a2001990041981-------y0itay0103----ba 101 0 $aita 102 $aIT 200 1 $aGuida mondiale dei transistori ad effetto di campo JFET e MOS$eequivalenze, caratteristiche elettriche e meccaniche, fabbricanti, distributori$fT.D.Towers, N. Stowers 205 $aEd. italiana 210 $dMilano, Jackson,1981 215 $a79 p.$d26 cm 312 $aTrad. di: towers' international jfet selector 312 $aTrad. di: Towers' international JFET selector 454 0$12001$aTowers' international JFET selector$91487863 610 1 $atransistors 676 $a621.381 700 1$aTowers,$bThomas Dundas$050971 702 1$aStowers,$bN 801 $aSistema bibliotecario di Ateneo dell' Università di Salerno$gRICA 912 $a990000136890203316 951 $a621.381 TOW$b10070/CBS$c621.381$d00327115 959 $aBK 969 $aSCI 979 $c19900424 979 $c20001110$lUSA01$h1711 979 $c20020403$lUSA01$h1621 979 $aPATRY$b90$c20040406$lUSA01$h1610 979 $aRSIAV6$b90$c20090911$lUSA01$h1236 996 $aTowers' international JFET selector$91487863 997 $aUNISA LEADER 02945nam 2200577 a 450 001 9910830264503321 005 20230213211623.0 010 $a1-280-58882-9 010 $a9786613618658 010 $a0-470-71936-2 010 $a0-470-71690-8 035 $a(CKB)1000000000687521 035 $a(EBL)703782 035 $a(SSID)ssj0000715138 035 $a(PQKBManifestationID)11377549 035 $a(PQKBTitleCode)TC0000715138 035 $a(PQKBWorkID)10700897 035 $a(PQKB)10229708 035 $a(MiAaPQ)EBC703782 035 $a(OCoLC)264621103 035 $a(EXLCZ)991000000000687521 100 $a20730216d1964 uy 0 101 0 $aeng 135 $aur|n|---||||| 181 $ctxt 182 $cc 183 $acr 200 10$aCiba Foundation Symposium$b[electronic resource] $ecellular biology of myxovirus infections /$fedited by G.E.W. Wolstenholme and Julie Knight 210 $aBoston $cLittle, Brown and Co.$d1964 215 $a1 online resource (381 p.) 225 1 $aCiba Foundation symposium 300 $aDescription based upon print version of record. 311 $a0-470-72280-0 320 $aIncludes bibliographical references and indexes. 327 $aCELLULAR BIOLOGY OF MYXOVIRUS INFECTIONS; Contents; Chairman's opening remarks; Thestructureof myxoviruses and Its biological significance; Discussion; The various virus-specific units produced by myxovirus-infected cells; Discussion; Effects of inhibitors of nucleic acid synthesis on the production of myxoviruses; Discussion; Labelling of cells infected with myxoviruses; Discussion; Effect of actinomycin D on the replication of Newcastle disease and influenza viruses; Discussion; Ro?le of the surface state in the development of myxoviruses; Discussion 327 $aEffect of progressive iodination of influenza virus on i t s biological propertiesDiscussion; Structure of myxoviruses; Terminology and classification of myxoviruses; Classification of influenza A viruses; Genetic studies with influenza A virus; Discussion; Genetic variants of influenza virus which differ in reactivity with receptors and antibodies; Discussion; The antibody response; Analytical, serological and clinical experiences with the haemagglutinating subunits of influenza A virus; Discussion; Persistent infection of L cell cultures by myxoviruses; Discussion 327 $aCellular and humoral factors of defence against virus infectionDiscussion; General Discussion 410 0$aCiba Foundation symposium. 606 $aOrthomyxoviruses$vCongresses 615 0$aOrthomyxoviruses 676 $a576.6 701 $aWolstenholme$b G. E. W$g(Gordon Ethelbert Ward)$063039 701 $aKnight$b Julie$0512647 712 02$aCiba Foundation. 801 0$bMiAaPQ 801 1$bMiAaPQ 801 2$bMiAaPQ 906 $aBOOK 912 $a9910830264503321 996 $aCiba Foundation Symposium$93004923 997 $aUNINA